Evidence map›Paper›PMID 32603325›Full record

ArticlePLoS neglected tropical diseases2020

First identification of genotypes of Enterocytozoon bieneusi (Microsporidia) among symptomatic and asymptomatic children in Mozambique.

Aly S Muadica, Augusto E Messa, Alejandro Dashti, Sooria Balasegaram, Mónica Santin, Filomena Manjate, Percina Chirinda, Marcelino Garrine, Delfino Vubil, Sozinho Acácio and 7 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Molecular epidemiology ofFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Exploring genetic variability ofFrontiers in microbiology · 2023
    Article
  8. Article
  9. Article
  10. Chronic Infections in Mammals Due to Microsporidia.Experientia supplementum (2012) · 2022
    Article
  11. Article
  12. Sparse Evidence forPathogens (Basel, Switzerland) · 2021
    Article
  13. Molecular Diversity ofPathogens (Basel, Switzerland) · 2021
    Article
  14. Article
  15. High Prevalence ofIranian journal of parasitology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Aly S MuadicaParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain.
Augusto E MessaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.ORCID 0000-0002-1794-2462
Alejandro DashtiParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain.ORCID 0000-0001-8707-5731
Sooria BalasegaramField Epidemiology Services, National Infection Service, Public Health England, London, United Kingdom.
Mónica SantinEnvironmental Microbial and Food Safety Laboratory, Agricultural Research Service, United States Department of Agriculture, Beltsville, Maryland, United States of America.ORCID 0000-0002-1386-6255
Filomena ManjateCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Percina ChirindaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Marcelino GarrineCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Delfino VubilCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Sozinho AcácioCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Pamela C KösterParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain.
Begoña BailoParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain.
Tacilta NhampossaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Rafael Calero-BernalSALUVET, Department of Animal Health, Faculty of Veterinary, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0003-2323-0135
Jason M MwendaFamily and Reproductive Health Cluster, World Health Organization (WHO) Regional Office for Africa, Congo Brazaville.
Inácio MandomandoCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
David CarmenaParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain.ORCID 0000-0002-4015-8553

Funding

World Health Organization 001
6 · The paper itself

Abstract

Enterocytozoon bieneusi is a human pathogen with a broad range of animal hosts. Initially, E. bieneusi was considered an emerging opportunistic pathogen in immunocompromised, mainly HIV-infected patients, but it has been increasingly reported in apparently healthy individuals globally. As in other African countries, the molecular epidemiology of E. bieneusi in Mozambique remains completely unknown. Therefore, we undertook a study to investigate the occurrence and genetic diversity of E. bieneusi infections in children with gastrointestinal symptoms as well as in asymptomatic children in Mozambique. Individual stool specimens were collected from 1,247 children aged between 0 and 14 years-old living in urban and rural settings in Zambézia (n = 1,097) and Maputo (n = 150) provinces between 2016 and 2019. Samples were analysed for E. bieneusi by nested-PCR targeting the internal transcribed spacer (ITS) region of the rRNA gene. All positive amplicons were confirmed and genotyped. Penalised logistic regression (Firth) was used to evaluate risk associations. The overall prevalence of E. bieneusi in this children population was 0.7% (9/1,247). A 10-fold higher prevalence was found in Maputo (4.0%; 6/150) than in Zambézia (0.3%; 3/1,097). All E. bieneusi-positive samples were from children older than 1-year of age, and most (8/9) from asymptomatic children. Nucleotide sequence analysis of the ITS region revealed the presence of four genotypes, three previously reported (Peru11, n = 1; Type IV, n = 2, and S2, n = 2) and a novel genotype (named HhMzEb1, n = 4). Novel genotype HhMzEb1 was identified in both asymptomatic (75%, 3/4) and symptomatic (25%, 1/4) children from a rural area in Maputo province in southern Mozambique. Genotypes HhMzEb1, Peru11, S2, and Type IV belonged to the Group 1 that includes genotypes with low host specificity and the potential for zoonotic and cross-species transmission. Being infected by enteric protozoan parasites and no handwashing were identified as risk associations for E. bieneusi infection. This study reports the first investigation of E. bieneusi genotypes in Mozambique with the identification of three previously reported genotypes in humans as well as a novel genotype (HhMzEb1). Findings highlight the need to conduct additional research to elucidate the epidemiology of E. bieneusi in the country, especially in rural areas where poor hygiene conditions still prevail. Special attention should be paid to the identification of suitable animal and environmental reservoirs of this parasite and to the characterization of transmission pathways.

Indexed as

GenotypeMolecular EpidemiologyAdolescentAfricaAnimalsChildChild, PreschoolCross-Sectional StudiesDNA, FungalEnterocytozoonFemaleGenetic VariationHost SpecificityHumansInfantInfant, NewbornDNA, Fungal

Identifiers

PMID32603325
PMCPMC7357779

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.